Home » Newsletters » BioWorld Science

BioWorld Science

Oct. 3, 2001

View Archived Issues

Pivotal trials of Sepracor's rapid- and long-acting bronchodilator initiated

Sibutramine metabolite in phase II for sexual dysfunction

Sepracor initiates clinical testing of new compound for anxiety

Forest seeks FDA approval for new calcium channel blocker

First target from Lexicon's drug discovery program unveiled

Uriach compound for IBD with unique mechanism of action licensed to Interneuron

Clinical trial in asthmatics demonstrates bronchoprotective effect for sildenafil

Clinical data discussed at ERS meeting support use of omalizumab in allergic asthma, rhinitis

NBI-34060 to move to phase III following positive phase II results

Promising phase II results obtained for BBR-2778 in non-Hodgkin's lymphoma

Study on stability of synthetic red blood cell substitute reported successful

New diagnostic test for mad cow and Creutzfeldt-Jakob disease enters clinical testing

rSP-C-based surfactant effective in acute lung injury when given as therapeutic lavage

CNS excitability reduced by rhubarb extracts in rat hippocampal neurons

ORP150: therapeutic potential in stroke

Good stability, favorable pharmacokinetics determined for LJP-920

Key pharmacokinetic findings, integrated phase III data analysis presented in Rome for Cialis

Pamidronate reduces bone loss in men on prostate cancer treatment

Teijin describes preparation and use of new chymase inhibitors

BMS discloses new series and uses of cannabinoid receptor modulators

Integrin antagonists under early development at Merck KGaA

Antiulcer agents from Sankyo inhibit H+/K+-ATPase and H. pylori

Newly claimed Rho kinase inhibitors with wide range of therapeutic applications

Advanced Medicine discloses new nicotinic acetylcholine receptor modulators and use as analgesics

MTP inhibitors from Advanced Medicine reportedly useful for atherosclerosis

Novel compounds for HCV infection patented by Schering-Plough

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 26, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 23, 2026.
Neurotrimin unveiled as marker in intellectual disability
BioWorld Science
Neurotrimin (NTM) is a member of the IgLON family, the disruption of which has been tied to emotional learning deficits and anxiety-like behavior in animal...
Biallelic variants in COX18 identified as cause of Charcot-Marie-Tooth disease
BioWorld Science
Charcot-Marie-Tooth (CMT) disease is a group of clinically and genetically heterogeneous sensorimotor peripheral neuropathies. It is the most frequent inherited...
Cell/gene therapy sector now sustainable; China competition mounting
BioWorld
There was an upbeat message for cell and gene therapy companies in the 2026 industry update presented as the J.P. Morgan Healthcare Conference opened on Monday,...